Orchid Pharma Ltd Quarterly Results

Gross Sales

237.48

217.34

222.7

244.41

217.1

Excise Duty

0

0

0

0

0

Net Sales

237.48

217.34

222.7

244.41

217.1

Other Operating Income

0

0

0

0

0

Other Income

3.9

8.49

7.52

7.57

13.36

Total Income

241.38

225.83

230.22

251.98

230.46

Total Expenditure

209.5

190.98

192.36

211.91

188.18

PBIDT

31.88

34.85

37.85

40.06

42.28

Interest

3.92

3.8

3.33

3.5

3.47

PBDT

27.97

31.06

34.53

36.56

38.8

Depreciation

8.87

8.61

8.63

8.44

8.42

Minority Interest Before NP

0

0

0

0

0

Tax

0.06

0

0

-0.15

0.11

Deferred Tax

-0.1

0

0

0

-3.23

Reported Profit After Tax

19.13

22.45

25.9

28.27

33.5

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

22.29

20.78

27.24

29.35

32.96

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

22.29

20.78

27.24

29.35

32.96

EPS (Unit Curr.)

4.4

4.1

5.37

5.79

6.81

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

50.72

50.72

50.72

50.72

50.72

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

13.42

16.03

16.99

16.39

19.47

PBDTM(%)

11.77

14.29

15.5

14.95

17.87

PATM(%)

8.05

10.32

11.62

11.56

15.43